Abstract

Flow based Enabling Synthetic Chemistry Technology

Stevan Djuric, Senior Director, Discovery Chemistry and Technology, AbbVie

Drug Discovery is nowadays considered a race. In this talk, we will describe our efforts to improve efficiency and scope of our medicinal chemistry operations through the use of a variety of flow chemistry based platforms. These include compound library synthesis using segmented flow technology and the access of novel structures through flow based photochemistry and electrochemistry based techniques. Recent efforts in the area of high temperature chemistry will also be presented.